Triton completes sale of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group
Luxembourg, 11 December 2024 - Funds advised by Triton (“Triton”), alongside co-investors, have successfully completed the sale of Blitz LuxCo Sarl, the holding company of Bormioli Pharma Group (“Bormioli” or “the company”), a leading producer of pharmaceutical packaging, to Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech, and cosmetics industries.
Bormioli was acquired by Triton in 2017 via a corporate carve out, having been identified as a future winner benefiting from increasing demand for sustainable packaging while providing drug stability and patient safety. The company has since been transformed into an important player in pharma packaging, present in over 100 countries, has approx. 1,400 employees with sales of approx. EUR 370 million in 2023.
Triton supported Bormioli’s development by bolstering its management team, reshaping its organisational and operational structure, expanding and upgrading the company’s manufacturing base with state-of-the-art technology, establishing one of the first pharma packaging solutions based upon recycled materials, and integrating four strategic acquisitions that bolstered its product portfolio and geographical presence.
About Triton
Founded in 1997 and owned by its partners, Triton is a leading European mid-market sector-specialist investor. Triton focuses on investing in businesses that provide mission critical goods and services in its three core sectors of Business Services, Industrial Tech, and Healthcare.
Triton has over 200 investment professionals across 11 offices and invests through three complementary “All Weather” strategies: Mid-Market Private Equity, Smaller Mid-Cap Private Equity, and Opportunistic Credit.